{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:50:05Z","timestamp":1790383805029,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.biomaterials.2019.119678","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T06:51:31Z","timestamp":1576479091000},"page":"119678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline"],"prefix":"10.1016","volume":"231","author":[{"given":"Xiaojun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"Alzheimer's disease facts and figures","volume":"12","author":"Association","year":"2016","journal-title":"Alzheimer's Dementia"},{"issue":"10043","key":"10.1016\/j.biomaterials.2019.119678_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"issue":"5580","key":"10.1016\/j.biomaterials.2019.119678_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119678_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"363","key":"10.1016\/j.biomaterials.2019.119678_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer's disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"7618","key":"10.1016\/j.biomaterials.2019.119678_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"issue":"386","key":"10.1016\/j.biomaterials.2019.119678_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2029","article-title":"Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy","volume":"9","author":"Yanamandra","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"10062","key":"10.1016\/j.biomaterials.2019.119678_bib9","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/S0140-6736(16)32107-9","article-title":"Targeting tau protein in Alzheimer's disease","volume":"388","author":"Rafii","year":"2016","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119678_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in Alzheimer's disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochem. Int."},{"issue":"s1","key":"10.1016\/j.biomaterials.2019.119678_bib12","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.3233\/JAD-2012-129011","article-title":"The metal theory of Alzheimer's disease","volume":"33","author":"Bush","year":"2013","journal-title":"J. Alzheimer's Dis."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119678_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/med.21434","article-title":"Drugs in clinical trials for alzheimer's disease: the major trends","volume":"37","author":"Bachurin","year":"2017","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrneurol.2014.44","article-title":"Alzheimer disease: lessons from immunotherapy for Alzheimer disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"7628","key":"10.1016\/j.biomaterials.2019.119678_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature20412","article-title":"The road to restoring neural circuits for the treatment of Alzheimer's disease","volume":"539","author":"Canter","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119678_bib20","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1073\/pnas.88.6.2288","article-title":"Straight and paired helical filaments in Alzheimer disease have a common structural unit","volume":"88","author":"Crowther","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/14737175.2016.1140039","article-title":"Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium","volume":"16","author":"Seripa","year":"2016","journal-title":"Expert Rev. Neurother."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer's disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119678_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/jpet.114.219352","article-title":"Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for alzheimer's disease","volume":"352","author":"Baddeley","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10062","key":"10.1016\/j.biomaterials.2019.119678_bib24","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119678_bib25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jalz.2016.06.006","article-title":"Therapeutic strategies for the treatment of tauopathies: hopes and challenges","volume":"12","author":"Khanna","year":"2016","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119678_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"6301","key":"10.1016\/j.biomaterials.2019.119678_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2019.119678_bib28","first-page":"2013","article-title":"Phosphorylation of tau protein as the link between oxidative stress","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2013","journal-title":"Mitochondrial Dysfunct. Connect. Fail.: Implications for Alzheimer\u2019s Dis."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer's Dis."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119678_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","article-title":"Metals, oxidative stress and neurodegenerative disorders","volume":"345","author":"Jomova","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119678_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"25","key":"10.1016\/j.biomaterials.2019.119678_bib32","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2019.119678_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","article-title":"Advances in metal-induced oxidative stress and human disease","volume":"283","author":"Jomova","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.biomaterials.2019.119678_bib34","series-title":"c. longevity, Oxidative stress and the pathogenesis of Alzheimer's disease","first-page":"316523","author":"Zhao","year":"2013"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119678_bib35","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acs.chemrev.8b00672","article-title":"Nanozymes: classification, catalytic mechanisms, activity regulation, and applications","volume":"119","author":"Huang","year":"2019","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/C8CS00457A","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)","volume":"48","author":"Wu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119678_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/21691401.2017.1313268","article-title":"Nanozyme applications in biology and medicine: an overview","volume":"45","author":"Golchin","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119678_bib38","first-page":"101","article-title":"Nanozyme: a new type of artificial enzyme","volume":"45","author":"Yan","year":"2018","journal-title":"Prog. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119678_bib39","first-page":"237","article-title":"Nanozymes in catalytic cancer theranostics","volume":"45","author":"Yang","year":"2018","journal-title":"Prog. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11427-016-5044-3","article-title":"Nanozymes: an emerging field bridging nanotechnology and biology","volume":"59","author":"Gao","year":"2016","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119678_bib41","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for alzheimer's disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2019.119678_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biomaterials.2016.05.005","article-title":"Ceria\/POMs hybrid nanoparticles as a mimicking metallopeptidase for treatment of neurotoxicity of amyloid-beta peptide","volume":"98","author":"Guan","year":"2016","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.biomaterials.2019.119678_bib43","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1039\/C6TB00396F","article-title":"Controlling the surface chemistry of cerium oxide nanoparticles for biological applications","volume":"4","author":"Gupta","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib44","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/acs.jpcc.5b09495","article-title":"Enhanced hydroxyl radical scavenging activity by doping lanthanum in ceria nanocubes","volume":"120","author":"Fernandez-Garcia","year":"2016","journal-title":"J. Phys. Chem. C"},{"issue":"38","key":"10.1016\/j.biomaterials.2019.119678_bib45","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.1002\/anie.201704904","article-title":"Ceria-zirconia nanoparticles as an enhanced multi-antioxidant for sepsis treatment","volume":"56","author":"Soh","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119678_bib46","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1021\/acsnano.6b05990","article-title":"Enabling prussian blue with tunable localized surface plasmon resonances: simultaneously enhanced dual-mode imaging and tumor photothermal therapy","volume":"10","author":"Cai","year":"2016","journal-title":"ACS Nano"},{"issue":"31","key":"10.1016\/j.biomaterials.2019.119678_bib47","doi-asserted-by":"crossref","first-page":"26108","DOI":"10.1021\/acsami.8b10345","article-title":"Prussian blue nanozyme with multienzyme activity reduces colitis in mice","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"18","key":"10.1016\/j.biomaterials.2019.119678_bib48","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1021\/jacs.5b12070","article-title":"Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers","volume":"138","author":"Zhang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119678_bib49","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/acs.nanolett.8b04729","article-title":"Hollow prussian blue nanozymes drive neuroprotection against ischemic stroke via attenuating oxidative stress, counteracting inflammation, and suppressing cell apoptosis","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2019.119678_bib50","first-page":"179","article-title":"Oxidative stress and redox-active iron in Alzheimer's disease","volume":"1012","author":"Honda","year":"2004","journal-title":"Redox-Active Metals in Neurological Disorders"},{"issue":"19","key":"10.1016\/j.biomaterials.2019.119678_bib51","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1039\/C4CS00005F","article-title":"Cholesterol and metal ions in Alzheimer's disease","volume":"43","author":"Lee","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119678_bib52","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1021\/jacs.5b13577","article-title":"Amyloid-beta and alpha-synuclein decrease the level of metal-catalyzed reactive oxygen species by radical scavenging and redox silencing","volume":"138","author":"Pedersen","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119678_bib53","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/nnm-2016-0019","article-title":"Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases","volume":"11","author":"Hernando","year":"2016","journal-title":"Nanomedicine"},{"issue":"18","key":"10.1016\/j.biomaterials.2019.119678_bib54","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1021\/acs.chemrev.5b00731","article-title":"Synthesis, properties, and applications of hollow micro-\/nanostructures","volume":"116","author":"Wang","year":"2016","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119678_bib55","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/anie.201310679","article-title":"Mesoporous prussian blue analogues: template-free synthesis and sodium-ion battery applications","volume":"53","author":"Yue","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"issue":"26","key":"10.1016\/j.biomaterials.2019.119678_bib56","first-page":"6825","article-title":"Novel magnetic functionalities of Prussian blue analogs","volume":"40","author":"Tokoro","year":"2011","journal-title":"DTr"},{"issue":"16","key":"10.1016\/j.biomaterials.2019.119678_bib57","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1039\/C4TA00062E","article-title":"Prussian blue analogues: a new class of anode materials for lithium ion batteries","volume":"2","author":"Nie","year":"2014","journal-title":"J. Mater. Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119678_bib58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/1521-4109(200106)13:10<813::AID-ELAN813>3.0.CO;2-Z","article-title":"Prussian Blue and its analogues: electrochemistry and analytical applications","volume":"13","author":"Karyakin","year":"2001","journal-title":"Electroanalysis"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/1673-5374.153679","article-title":"Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer's disease","volume":"10","author":"Kamat","year":"2015","journal-title":"Neural regeneration research"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-002-0657-y","article-title":"Role of protein kinase B in Alzheimer's neurofibrillary pathology","volume":"105","author":"Pei","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119678_bib61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of alzheimer's disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6559","key":"10.1016\/j.biomaterials.2019.119678_bib62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen-synthase kinase-3 by insulin-mediated by protein-kinase-B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119678_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease, Brain research","volume":"109","author":"Pei","year":"2002","journal-title":"Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119678_bib64","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-004-0820-8","article-title":"Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease","volume":"107","author":"Lee","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2478\/s13380-014-0225-7","article-title":"Neuroinflammation and Alzheimer's disease: lessons learned from 5-lipoxygenase","volume":"5","author":"Joshi","year":"2014","journal-title":"Transl. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2019.119678_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-2006-102-303","article-title":"Metals and Alzheimer's disease","volume":"10","author":"Adlard","year":"2006","journal-title":"J. Alzheimer's Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119678_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-2005-8211","article-title":"Iron, neuroinflammation, and Alzheimer's disease","volume":"8","author":"Ong","year":"2005","journal-title":"J. Alzheimer's Dis."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119678_bib68","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s11064-007-9360-7","article-title":"Iron: the Redox-active center of oxidative stress in Alzheimer disease","volume":"32","author":"Castellani","year":"2007","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119678_bib69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3233\/JAD-140534","article-title":"High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-\u03b2 related cognitive impairment","volume":"42","author":"Tong","year":"2014","journal-title":"J. Alzheimer's Dis."},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119678_bib70","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/15563650601181562","article-title":"Quantitative measurement of cyanide released from prussian blue","volume":"45","author":"Yang","year":"2007","journal-title":"Clin. Toxicol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930777X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930777X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:48:31Z","timestamp":1758905311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121930777X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":70,"alternative-id":["S014296121930777X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119678","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119678"}}